Xinghe Xue

Xinghe Xue

Auto-generated profile, based on publicly available information

Xinghe Xue

Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second Clinical School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
CLChao Lou
Chao Lou
HJHongyi Jiang
Hongyi Jiang
ZLZhongnan Lin
Zhongnan Lin
TXTian Xia
Tian Xia
WWWeidan Wang
Weidan Wang
XXXinghe Xue
Xinghe Xue
Osteoarthritis (OA) is a common degenerative joint disease characterized by progressive cartilage degradation and inflammation. In recent years, mesenchymal stem cells (MSCs) derived exosomes (MSCs-Exo) have attracted widespread attention for their potential role in modulating OA pathology. However, the unpredictable therapeutic effects of exosomes have been a significant barrier to their extensive clinical application. In this study, we investigated whether fucoidan-pretreated MSC-derived exosomes (F-MSCs-Exo) could better protect chondrocytes in osteoarthritic joints and elucidate its underlying mechanisms. In order to evaluate the role of F-MSCs-Exo in osteoarthritis, both in vitro and in vivo studies were conducted. MiRNA sequencing was employed to analyze MSCs-Exo and F-MSCs-Exo, enabling the identification of differentially expressed genes and the exploration of the underlying mechanisms behind the protective effects of F-MSCs-Exo in osteoarthritis. Compared to MSCs-Exo, F-MSCs-Exo demonstrated superior effectiveness in inhibiting inflammatory responses and extracellular matrix degradation in rat chondrocytes. Moreover, F-MSCs-Exo exhibited enhanced activation of autophagy in chondrocytes. MiRNA sequencing of both MSCs-Exo and F-MSCs-Exo revealed that miR-146b-5p emerged as a promising candidate mediator for the chondroprotective function of F-MSCs-Exo, with TRAF6 identified as its downstream target. In conclusion, our research results demonstrate that miR-146b-5p encapsulated in F-MSCs-Exo effectively inhibits TRAF6 activation, thereby suppressing inflammatory responses and extracellular matrix degradation, while promoting chondrocyte autophagy for the protection of osteoarthritic cartilage cells. Consequently, the development of a therapeutic approach combining fucoidan with MSC-derived exosomes provides a promising strategy for the clinical treatment of osteoarthritis.

1 April 2014 in Injury
Verified
Journal Article
Closed access
XXXing-He Xue
Xing-He Xue
SYShi-Gui Yan
Shi-Gui Yan
XCXun-Zi Cai
Xun-Zi Cai
MSMing-Min Shi
Ming-Min Shi
TLTiao Lin
Tiao Lin

16 June 2015 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
ALAn Liu
An Liu
MSMiao Sun
Miao Sun
CMChiyuan Ma
Chiyuan Ma
YCYunlin Chen
Yunlin Chen
XXXinghe Xue
Xinghe Xue
SYShigui Yan
Shigui Yan

21 March 2019 in Food & Function
Verified
Journal Article
Closed access
PDF file
ZLZucheng Luo
Zucheng Luo
BZBinbin Zheng
Binbin Zheng
BJBingjie Jiang
Bingjie Jiang
XXXinghe Xue
Xinghe Xue
EXEnxing Xue
Enxing Xue
YZYulong Zhou
Yulong Zhou
Osteoarthritis (OA) is a common arthrosis characterized by degeneration and inflammation of articular cartilage. In recent decades, peiminine (Pm) has been identified as one of the active ingredients of Fritillaria plants. According to reports, Pm has a potent anti-inflammatory effect in various diseases. However, the effectiveness of Pm as an anti-inflammatory in OA has not previously been reported. This research aims to evaluate the anti-inflammatory effect of Pm on interleukin (IL)-1β-induced mice chondrocytes and its chondroprotective effect in a mouse OA model with surgical destabilization of the medial meniscus. IL-1β-induced expression of nitric oxide (NO), prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), tumor necrosis factor alpha (TNF-α), inducible nitric oxide synthase (iNOS) and interleukin-6 (IL-6) were all inhibited significantly by Pm pretreatment in vitro. In addition, Pm also inhibited the expression of thrombospondin motifs 5 (ADAMTS-5) and matrix metalloproteinase-13 (MMP-13), which are responsible for the degradation of the extracellular matrix (ECM). Additionally, the degradation of aggrecan and collagen II was reversed by Pm. Furthermore, Pm inhibited Akt phosphorylation and the nuclear transfer of nuclear factor-κB (NF-κB) and activated Nrf2/HO-1 signaling pathways both in vitro and in vivo. These findings suggested that Pm alleviated inflammatory effects in the IL-1β-induced chondrocytes. Therefore, Pm might be a potential therapeutic agent for OA.

22 July 2020 in Food & Function
Verified
Journal Article
Closed access
PDF file
JZJingdi Zhan
Jingdi Zhan
ZYZijian Yan
Zijian Yan
MZMengyao Zhao
Mengyao Zhao
WQWeihui Qi
Weihui Qi
JLJian Lin
Jian Lin
XXXinghe Xue
Xinghe Xue
Steroid-induced avascular necrosis of the femoral head (SANFH) is a major complication of long-term or excessive clinical use of glucocorticoids. Allicin is a classical ingredient extracted from garlic and has many functions such as anti-apoptosis and antibacterial effects. The purpose of this study was to investigate the effect and the mechanism of allicin on apoptosis of osteoblasts induced by dexamethasone (Dex) and SANFH in rats. In vitro, we performed CCK-8, western blotting, TUNEL and other experiments, and the results of these experiments showed that allicin could inhibit the Dex-induced abnormal expression of C-caspase3, C-caspase9, Bax, cytochrome C and Bcl-2 by activating the PI3K/AKT pathway. In vivo, the results of micro-CT, hematoxylin–eosin staining and immunohistochemical analysis suggested that allicin could effectively inhibit the progress of SANFH in rats. In summary, our experiments indicate that allicin is a potential drug for the treatment of SANFH.

1 November 2018 in International Immunopharmacology
Verified
Journal Article
Closed access
JLJian Lin
Jian Lin
XLXiaobin Li
Xiaobin Li
WQWeihui Qi
Weihui Qi
YYYingzhao Yan
Yingzhao Yan
KCKai Chen
Kai Chen
XPXiaoyun Pan
Xiaoyun Pan